Delivery Order SPE2DB22D1017-SPE2DB25FG9FK
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 11, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a ceiling value of $2,275.62. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,187.99 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a firm fixed price of $1,332.35. This delivery order, issued without set-aside designation, is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units, with a ceiling value of $1,109.30. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,308.60 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) under a firm fixed-price contract. The order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Azathioprine 50 mg tablets (100-count) under a firm fixed-price contract valued at $3,469.06. This is a non-set-aside award issued as a child delivery order, with performance at the contractor's Conshohocken, Pennsylvania facility and an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,905.81 for Azathioprine 50 mg tablets (100-count units) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract employs firm fixed pricing and represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,073.88 to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4,564,883,923 units of the medication Azathioprine 50 mg tablets. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a ceiling value of $2,056.22. This non-competitive, firm fixed-price delivery order is set to be completed by August 4, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Azathioprine 50 mg tablets (100-count units) valued at $2,679.17. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and no set-aside designation was used. The award represents a competitive procurement from AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9FKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) under a firm fixed price contract with a ceiling value of $3,600.48. This non-set-aside, competitively awarded delivery order is set for ultimate completion on August 11, 2025, and represents a continuation of the company's pharmaceutical supply support to federal healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 total value through December 2026. As a prime pharmaceutical vendor for the DLA Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of medications and medical supplies supporting military and veteran healthcare systems globally. The company's established relationship with DLA reflects its demonstrated capability to meet federal procurement requirements through open competition and deliver critical pharmaceutical commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/8/25 |